Skip Nav Destination
Issues
1 August 2023
-
Cover Image
Cover Image
The cover image is adapted from Fig. 1 in the article, “Incidence and Mortality Rates for Childhood Acute Lymphoblastic Leukemia in Puerto Rican Hispanics, 2012–2016,” by Montes-Rodríguez and colleagues. Acute lymphoblastic leukemia (ALL) accounts for 80% of all leukemias diagnosed in children. In the United States (US), ALL accounts for 27% of cancers diagnosed in children ages 0 to 19 years, disproportionately affecting children between 2 and 5 years. Even though the age patterns of ALL are consistent across racial and ethnic groups, the incidence and survival rates are highly variable. Several studies have reported higher incidence and lower survival rates for some Hispanic subpopulations in the US (USH). However, to date, there have been no reports on childhood ALL in Puerto Rican Hispanics (PRH). According to the United States Census Bureau Puerto Rico: 2020 Census, the population of Puerto Rico is 98.9% Hispanic or Latino (RRID: SCR_011587). The authors report the first estimates of childhood ALL incidence, mortality, and survival rates in PRH and compare them with other racial/ethnic groups in the US. PRH children had 31% lower incidence rates than USH, but 86% higher incidence rates than non-Hispanic Blacks. In addition, the incidence trends of ALL increased significantly from 2001 to 2016 among PRH and USH, 5% and 0.9% per year, respectively. Moreover, PRH have a lower 5-year overall survival (81.7%) when compared to other racial/ethnic groups. The information revealed in this study will serve as a guide for future research on this minority population. For more information, see the article beginning on page 1030. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1055-9965
EISSN 1538-7755
Issue Sections
Highlights
Commentaries
Reviews
Research Articles
The Association of Neighborhood Characteristics and Frailty in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort Study
Lindsay F. Schwartz; Rikeenkumar Dhaduk; Carrie R. Howell; Tara M. Brinkman; Matthew J. Ehrhardt; Angela Delaney; Deo Kumar Srivastava; Jennifer Q. Lanctot; Gregory T. Armstrong; Leslie L. Robison; Melissa M. Hudson; Kirsten K. Ness; Tara O. Henderson
Field Synopsis of Environmental and Genetic Risk Factors of Sporadic Early-Onset Colorectal Cancer and Advanced Adenoma
Rongqi Zhang; Daniel Boakye; Nan Yang; Xuan Zhou; Yajing Zhou; Fangyuan Jiang; Lili Yu; Lijuan Wang; Jing Sun; Shuai Yuan; Jie Chen; Ashleigh C. Hamilton; Helen G. Coleman; Susanna C. Larsson; Julian Little; Malcolm G. Dunlop; Edward L. Giovannucci; Evropi Theodoratou; Xue Li
Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium
Kate Gersekowski; Torukiri I Ibiebele; for the Australian Ovarian Cancer Study Group; Jennifer A. Doherty; Holly R. Harris; Marc T. Goodman; Kathryn L. Terry; Anna H. Wu; Elisa V. Bandera; Bo Qin; Jue-Sheng Ong; Jonathan P. Tyrer; Suzanne C. Dixon-Suen; Francesmary Modugno; Harvey A Risch; Penelope M. Webb
Cost-effectiveness of Human Papillomavirus Self-collection Intervention on Cervical Cancer Screening Uptake among Underscreened U.S. Persons with a Cervix
Lisa P. Spees; Caitlin B. Biddell; Jennifer S. Smith; Andrea C. Des Marais; Michael G. Hudgens; Busola Sanusi; Sarah Jackson; Noel T. Brewer; Stephanie B. Wheeler
Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes
Mandeep Kaur; Anne Patterson; Julissa Molina-Vega; Harriet Rothschild; Elle Clelland; Cheryl A. Ewing; Firdows Mujir; Laura J. Esserman; Olufunmilayo I. Olopade; Rita A. Mukhtar
Null Results in Brief
Associations between Etiologic or Prognostic Tumor Tissue Markers and Neighborhood Contextual Factors in Male Health Professionals Diagnosed with Prostate Cancer
Hari S. Iyer; Kevin H. Kensler; Jane B. Vaselkiv; Konrad H. Stopsack; Charlotte Roscoe; Elisa V. Bandera; Bo Qin; Thomas L. Jang; Tamara L. Lotan; Peter James; Jaime E. Hart; Lorelei A. Mucci; Francine Laden; Timothy R. Rebbeck
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.